Skip to main content

Advertisement

SpringerLink
Log in

Bedside Measures of Frailty and Cognitive Function Correlate with Sarcopenia in Patients with Cirrhosis

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Frailty and sarcopenia are associated with mortality and poor outcomes among patients with cirrhosis. Frailty is multifactorial but due in part to sarcopenia and cognitive dysfunction. Data are limited regarding the correlation of bedside frailty and cognitive function measures with sarcopenia.

Aims

To evaluate the correlations between frailty measures and muscle indices from computed tomography (CT).

Methods

We prospectively enrolled 106 patients with clinically compensated cirrhosis (and no prior hepatic encephalopathy). All patients underwent CT scan and cognitive testing (via inhibitory control test, ICT), and were subject to hand grip, 30-s chair stands, mid-arm muscle area (MAMA), and a four-question algorithm based on the Sickness Impact Profile (SIP) predictive of minimal HE. We evaluated Spearman correlations between all measures as well as the sensitivity and specificity of each measure for falls.

Results

In total, 106 (35.3%) patients (55 men) had CT scans to measure skeletal muscle area and quality. Hand grip correlated strongly with skeletal muscle area (correlation coefficient 0.64, p < 0.001) and mildly with ICT performance (0.34, p = 0.002). However, for women, the strongest correlation with hand grip was ICT performance (0.60, p < 0.001). Chair stand performance correlated best with SIP (correlation coefficient − 0.35, p < 0.001). MAMA was not correlated with CT-based muscle indices among women but was for men. Poor chair stand performance (< 10/30-s) had a sensitivity/specificity for falls of 73%/54%; low muscle radiation attenuation (density) was 40%/80% sensitive/specific.

Conclusion

Bedside measures of physical function, muscle bulk, and cognitive performance are correlated with CT-based muscle measures. Bedside measures of frailty may provide an advantage over sarcopenia for outcome assessment that should be confirmed prospectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Estes C, Razavi H, Loomba R, et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67:123–133.

    Article  CAS  Google Scholar 

  2. Su F, Yu L, Berry K, et al. Aging of liver transplant registrants and recipients: trends and impact on waitlist outcomes, post-transplantation outcomes, and transplant-related survival benefit. Gastroenterology. 2016;150:441.e6–453.e6.

    Article  Google Scholar 

  3. Kanwal F, Tansel A, Kramer JR, et al. Trends in 30-day and 1-year mortality among patients hospitalized with cirrhosis from 2004 to 2013. Am J Gastroenterol. 2017;112:1287.

    Article  Google Scholar 

  4. Kobashigawa J, Dadhania D, Bhorade S, et al. Report from the American Society of Transplantation on frailty in solid organ transplantation. Am J Transplant. 2019;19:984–994.

    Article  Google Scholar 

  5. Lai JC, Covinsky KE, McCulloch CE, et al. The Liver Frailty Index improves mortality prediction of the subjective clinician assessment in patients with cirrhosis. Am J Gastroenterol. 2018;113:235.

    Article  Google Scholar 

  6. Tapper EB, Finkelstein D, Mittleman MA, et al. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 2015;62:584–590.

    Article  Google Scholar 

  7. Lai JC, Sonnenday CJ, Tapper EB, et al. Frailty in liver transplantation: an expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice. Am J Transplant. 2019;19:1896–1906.

    PubMed  Google Scholar 

  8. Englesbe MJ, Patel SP, He K, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg. 2010;211:271–278.

    Article  Google Scholar 

  9. Carey EJ, Lai JC, Wang CW, et al. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transplant. 2017;23:625–633.

    Article  Google Scholar 

  10. Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J, et al. Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis. Clin Transl Gastroenterol. 2015;6:e102.

    Article  Google Scholar 

  11. Laube R, Wang H, Park L, et al. Frailty in advanced liver disease. Liver Int. 2018;38:2117–2128.

    Article  Google Scholar 

  12. Force UPST. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement. Ann Intern Med. 2004;140:554.

    Article  Google Scholar 

  13. Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol Ser A Biomed Sci Med Sci. 2014;69:547–558.

    Article  Google Scholar 

  14. Lai JC, Covinsky KE, Dodge JL, et al. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017;66:564–574.

    Article  Google Scholar 

  15. Frisancho AR. New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly. Am J Clin Nutr. 1984;40:808–819.

    Article  CAS  Google Scholar 

  16. Bajaj JS, Hafeezullah M, Franco J, et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology. 2008;135:1591.e1–1600.e1.

    Article  Google Scholar 

  17. Amodio P, Ridola L, Schiff S, et al. Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology. 2010;139:510.e2–518.e2.

    Article  Google Scholar 

  18. Nabi E, Thacker LR, Wade JB, et al. Diagnosis of covert hepatic encephalopathy without specialized tests. Clin Gastroenterol Hepatol. 2014;12:1384.e2–1389.e2.

    Article  Google Scholar 

  19. Englesbe MJ, Lee JS, He K, et al. Analytic morphomics, core muscle size, and surgical outcomes. Ann Surg. 2012;256:255–261.

    Article  Google Scholar 

  20. Krishnamurthy V, Zhang P, Ethiraj S, et al. Use of analytic morphomics of liver, spleen, and body composition to identify patients at risk for cirrhosis. Clin Gastroenterol Hepatol. 2015;13:360.e5–368.e5.

    Article  Google Scholar 

  21. Singal AG, Zhang P, Waljee AK, et al. Body composition features predict overall survival in patients with hepatocellular carcinoma. Clin Transl Gastroenterol. 2016;7:e172.

    Article  CAS  Google Scholar 

  22. Derstine BA, Holcombe SA, Ross BE, et al. Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population. Sci Rep. 2018;8:11369.

    Article  Google Scholar 

  23. Tapper EB, Konerman M, Murphy S, et al. Hepatic encephalopathy impacts the predictive value of the Fried Frailty Index. Am J Transplant. 2018;18:2566–2570.

    Article  Google Scholar 

  24. Ebadi M, Tandon P, Moctezuma-Velazquez C, et al. Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis. J Hepatol. 2018;69:608–616.

    Article  Google Scholar 

  25. Tapper EB, Jiang ZG, Patwardhan VR. Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy. Mayo Clin Proc. 2015;90:646–658.

    Article  CAS  Google Scholar 

  26. Wang CW, Feng S, Covinsky KE, et al. A comparison of muscle function, mass, and quality in liver transplant candidates: results from the Functional Assessment in Liver Transplantation (FrAILT) study. Transplantation. 2016;100:1692.

    Article  Google Scholar 

  27. Tapper EB, Parikh ND, Waljee AK, et al. Diagnosis of minimal hepatic encephalopathy: a systematic review of point-of-care diagnostic tests. Am J Gastroenterol. 2018;113:529–538.

    Article  Google Scholar 

Download references

Funding

Elliot Tapper receives funding from the National Institutes of Health through the Michigan Institute for Clinical and Health Research (KL2TR002241).

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, University of Michigan, 3912 Taubman, SPC 5362, 1500 E Medical Center Dr, Ann Arbor, MI, 48109, USA

    Elliot B. Tapper & Grace L. Su

  2. Gastroenterology Section, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA

    Elliot B. Tapper & Grace L. Su

  3. Morphomic Analysis Group, University of Michigan, Ann Arbor, MI, USA

    Brian Derstine

  4. University of Michigan, Ann Arbor, MI, USA

    Jad Baki

Authors
  1. Elliot B. Tapper
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian Derstine
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jad Baki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Grace L. Su
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elliot B. Tapper.

Ethics declarations

Conflict of interest

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Elliot Tapper is the guarantor of this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tapper, E.B., Derstine, B., Baki, J. et al. Bedside Measures of Frailty and Cognitive Function Correlate with Sarcopenia in Patients with Cirrhosis. Dig Dis Sci 64, 3652–3659 (2019). https://doi.org/10.1007/s10620-019-05713-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-019-05713-4

Keywords

Search

Navigation